Controverse sur le traitement initial de la maladie de Parkinson : L-dopa ou agonistes dopaminergiques ?;Controverse sur le traitement initial de la maladie de Parkinson : L-dopa ou agonistes dopaminergiques ?

Revue Neurologique

Volumn 155, Issue 1, 1999, Pages 43-45

  Defer, G L ^a  

^a CHU CÔTE DE NACRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

COMPARATIVE STUDY; HUMAN; NOTE; PARKINSON DISEASE; TIME;

ANTIPARKINSON AGENTS; DOPAMINE AGONISTS; HUMANS; LEVODOPA; PARKINSON DISEASE; TIME FACTORS;

EID: 0032619788     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. BLANDINI F., GREENAMYRE J.T. (1998). Prospects of glutamate antagonists in the therapy of Parkinson's disease. Fundam Clin Phanmacol, 12:4-12.
2. BORDET R., RlDRAY S., CARBONI S., DlAZ J., SOKOLOFF P., SCHWARTZ J.S. (1997). Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc Natl Cad Sei USA 94:3363-3367.
3. BROUSSOLLE E. (1998). Arguments en faveur du traitement initial de la maladie de Parkinson par la L-Dopa, Rev Neurol, 1545 ; 1, 27-33.
4. CAUNE D.B. (1994). Initiating treatment for idiopathic parkinsonism. Neurology, 44 (Suppl 6) : S19-S22.
5. JANKOVIC J., SHOULSON l., WEINER W.J. (1994). Early-stage Parkinson's disease : To treat or not to treat. Neurology, 44 (Suppl 1): S4-S7.
6. KOLLER W.C., SILVER D.E., LIEBERMAN A. (1994). An Algorithm for the management of Parkinson's Disease. Neurology, 44 (Suppl 10): S9-S19.
7. MONTASTRUC J.L., RASCOL O., RASCOL A. (1989). A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients : a 3 year follow-up. J Neural Neurosurg Psychiatry 52:773-775.
8. 18F] dopa PET findings in early Parkinson's disease. J Neurol Neurosurg Psychiatry, 59:597-600.
9. 18F] dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain, 119:585-591.
10. QUINN N. (1995). Drugs treatment of Parkinson's disease. BMJ, 310:575-579.
11. RASCOL O. (1998). Arguments en faveur d'un traitement précoce de la maladie de Parkinson par les agonistes dopaminergiques. Rev Neurol, 155:1, 35-42.
12. WATTS R.L. (1997). The role of dopamine agonists in early Parkinson's Disease. Neurology, 49 (Suppl. 1): S34-S48.